Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 2A receptor (5-HT₂A) is a subtype of the serotonin receptor family and a G protein-coupled receptor (GPCR). It is the main excitatory GPCR for serotonin in the central nervous system, coupled to Gq/11 proteins and activating the PLC/IP3/DAG pathway. It is highly expressed in cortical regions and plays a critical role in cognition, mood regulation, and mediating the effects of hallucinogens. It's also implicated in neuropsychiatric disorders like depression and schizophrenia and targeted by antipsychotic drugs.
Agonism induces altered perception/cognition via enhanced cortical neuron plasticity. Antagonism results in antipsychotic/antidepressant effects.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor 5-HT₂A (None).